I was attracted to Incyte for its immuno-oncology pipeline. When I first joined Incyte as a Scientific Director, Immuno-Oncology in U.S. Medical Affairs, I had the opportunity to support the growing pipeline, explore novel biology and enable our therapeutics into clinical practice.
Delaware’s second annual community-led Startup302 funding competition is accepting applications from underrepresented founders with early-stage, technology-enabled ventures through Feb. 20. Focusing on underrepresented founders with a goal of tackling funding inequities and strengthening the regional startup community, the contest is offering more than $150,000 in non-dilutive grant prizes to winners along with mentoring and valuable networking connections such as introductions to potential investors.
Delaware’s booming life sciences sector continues to expand with plans by Analytical Biological Services Inc. (ABS) to double its workforce over the next three years.
The internationally recognized bioscience services company is retrofitting 30,000 square feet of space in New Castle for its new office headquarters and lab space. The expansion, supported by two grants from the Delaware Strategic Fund, will allow the company to meet significant projected growth and add 36 new high-paying, full-time, skilled trade and professional-level positions – more than doubling its current workforce – to the state’s economy.
Delaware’s General Assembly has approved allocating an additional $10 million to its lab grant program, which debuted last fall and is designed to spur private sector-led projects that will boost science and tech companies who choose Delaware with increased capacity for ready-to-go lab space.
ThruPore Technologies Inc., a market-disrupting, woman-led company with locations in Delaware and Alabama that is known for its Dr. Filter product, has chosen Newark as its site for expansion and continued innovation in chemistry and air filtration.